Status: Not yet recruiting
The Pilot Experimental Study of the Neuroprotective Effects of Exosomes in Extremely Low Birth Weight Infants
To study the safety and efficacy of intranasal administration of exosomes derived from mesenchymal stromal cells on long-term neurodevelopmental outcome in extremely low birth weight infants born at gestational age 25/0-27/6 weeks.
Participants needed: 10
Trial details
Age: 1-3Biological sex: AllType: InterventionalSponsor: Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of HealthcareUpdated: Sep 28, 2022Locations: 1
Eligibility criteria
Missing written parental consent [+7]